Gamma Biosciences is a brand that enables the promise of advanced therapies in the biopharmaceutical industry. Their operating companies work with biopharmaceutical innovators and manufacturers to deliver complex therapies to patients quickly and efficiently. They offer a range of products and services in various areas, including cell and gene therapies, vaccines, and biologics.

Gamma Biosciences is committed to advancing the science and art of bioprocessing. They continuously seek out and develop new approaches to biomanufacturing that facilitate the delivery of advanced therapies. Their operating companies, such as Mirus Bio, BioMagnetic Solutions, and Nirrin Technologies, provide innovative solutions in gene delivery, immunomagnetic cell separation systems, and sensors and analytics, respectively.

They have also acquired companies like Univercells Technologies and Astrea Bioseparations Ltd, which offer intensified and integrated platforms for manufacturing as well as expertise in affinity chromatography and bioseparations. With a focus on innovation and collaboration, Gamma Biosciences is driving advancements in the biopharmaceutical industry to improve patient outcomes